Erguven, M. Et Al. 2012. Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine. ONCOLOGY LETTERS , vol.3 , 200-208.

Erguven, M., Bilir, A., Yazihan, N., Korkmaz, S., Aktas, E., Ovalioglu, C., ... Dundar, T.(2012). Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine. ONCOLOGY LETTERS , vol.3, 200-208.

Erguven, Mine Et Al. "Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine," ONCOLOGY LETTERS , vol.3, 200-208, 2012

Erguven, Mine Et Al. "Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine." ONCOLOGY LETTERS , vol.3, pp.200-208, 2012

Erguven, M. Et Al. (2012) . "Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine." ONCOLOGY LETTERS , vol.3, pp.200-208.

@article{article, author={Mine Erguven Et Al. }, title={Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine}, journal={ONCOLOGY LETTERS}, year=2012, pages={200-208} }